Morbidity in patients on long-term steroid replacement therapy

Clinical Endocrinology

Volumn 72, Issue 4, 2010, Pages 564-566

  Druce, M R ^a   Akker, S A ^a   Chew, S L ^a   Drake, W M ^a   Grossman, A B ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; HYDROCORTISONE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ADRENAL TUMOR; ADRENALECTOMY; CANCER RECURRENCE; GONADOTROPHIN DEFICIENCY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HOSPITAL ADMISSION; HUMAN; LETTER; LONG TERM CARE; MEDICAL AUDIT; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; REPEAT PROCEDURE; TREATMENT DURATION;

ADRENAL INSUFFICIENCY; ADRENALECTOMY; ADULT; AGED; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; LONDON; MALE; MEDICAL AUDIT; MIDDLE AGED; MORBIDITY;

EID: 77749295073     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03656.x     Document Type: Letter

References (5)

1. Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A. et al. (2006) Premature mortality in patients with Addison's disease: a population-based study. Journal of Clinical Endocrinology and Metabolism, 91, 4849 4853.
2. Erichsen, M.M., Løvås, K., Fougner, K.J. et al. (2009) Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. European Journal of Endocrinology, 160, 233 237.
3. Løvås, K., Loge, J.H. Husebye, E.S. (2002) Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf), 56, 581 588.
4. Tomlinson, J.W., Holden, N., Hills, R.K. et al. (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet, 357, 425 431.
5. Asari, R., Scheuba, C., Kaczirek, K. et al. (2006) Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Archives of Surgery, 141, 1199 1205.